Fig. 5From: MUC3A promotes the progression of colorectal cancer through the PI3K/Akt/mTOR pathwayMUC3A regulated the growth and cell cycle of CRC and through the PI3K/AKT/mTOR signaling pathway. A The proliferation of MUC3A knockout cells (KO1, KO2) and control cells (NC) treated with the mTOR inhibitor rapamycin (1 µM for 4 h). B C Cell cycle of CRC cells treated with rapamycin. D E Expression of p21 and p53 in CRC cells treated with rapamycinBack to article page